Antiprotozoal drugs: challenges and opportunities

Click to increase image sizeClick to decrease image size

Declaration of interests

CT Supuran is Editor-in-Chief of the Expert Opinion on Therapeutic Patents. He was not involved in the assessment, peer review, or decision-making process of this paper. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.